Keyphrases
Randomized Placebo-controlled Trial
100%
Secondary Recurrent Miscarriage
100%
Intravenous Immunoglobulin (IVIg)
100%
Intravenous Immunoglobulin Therapy
100%
Live Birth Rate
60%
Placebo
40%
Placebo Groups
40%
Neonatal Survival
20%
Albumin
20%
Early Pregnancy
20%
Miscarriage
20%
Recurrent Miscarriage
20%
Single Center
20%
Pregnancy Loss
20%
Relative Risk
20%
Clinical Practice
20%
Gestational Week
20%
Birth Weight
20%
Intention-to-treat Analysis
20%
Per-protocol Analysis
20%
Denmark
20%
Copenhagen
20%
Tertiary Care Hospital
20%
Repeated Infusions
20%
Pregnancy Test
20%
Medicine and Dentistry
Immunoglobulin
100%
Recurrent Miscarriage
100%
Placebo
100%
Birth Rate
50%
Infusion
33%
Newborn Mortality
16%
Birth Weight
16%
Intention-to-Treat Analysis
16%
First Trimester Pregnancy
16%
Spontaneous Abortion
16%